Introduction
Odontogenic tumors are those lesions which originate from odontogenic epithelium. They remain entrapped, either within the jaws or in adjacent soft tissues (1) . They can be classified by location (peripheral or central) and biologic behavior as benign or malignant. However, the most accepted World Health Organization (WHO) classification has divided them into three subclasses: epithelial, mesenchymal, and mixed (2, 3) .
From a biological point perspective, some of these lesions represent hamartomas with various degrees of differentiation, while the rest are benign or malignant neoplasms with variable behavior (2) . Therefore, it is very important to form a set of criteria such as age, gender, and location of lesion, in the management of these tumors. In the present study, odontogenic tumors were evaluated in an Iranian population over a 30-year period.
Odontogenic tumors in an Iranian population:
a 30-year evaluation Nasrollah Saghravanian 1) , Hamid Jafarzadeh 2) , Nazanin Bashardoost 1) , Nooshin Pahlavan 3) and Iman Shirinbak 4) Mashhad, Iran served as the source of this 30-year retrospective study . All patients with lesions diagnosed as odontogenic tumor, were confirmed by microscopic reevaluation. Statistical analysis was performed using SPSS software (v. 13, SPSS Inc., Chicago, IL, US).
Results
Among 8,766 patients, only 165 cases were diagnosed as odontogenic tumors (1.9%). Odontogenic tumors were more common in females and in the second or third decades of life with greater frequency in the posterior region of the mandible (Table 1 ). According to the WHO classification (2005), 88 cases of these diagnosed tumors were epithelial odontogenic tumors (EOT = 53.4%), 54 were mixed odontogenic tumors (MixOT = 32.7%), and 23 were mesenchymal odontogenic tumors (MOT = 13.9%) ( Table  2 ). These data revealed that 98.2% of the tumors were benign and only three (1.8%) were malignant ameloblastoma, which were seen only in males.
Ameloblastoma consisting of all histological types ( Fig.  1 ) was the most common odontogenic tumor (70 cases; 42.4%); followed by odontoma (44 cases; 26.7%); and odontogenic myxoma tumor and adenomatoid odontogenic tumor (15 cases each; 9.1%) (Fig. 2) . The rest were other tumors (21 cases; 12.7%) ( Table 3) .
Centrally located tumors accounted for 158 cases (95.7%); whereas, only 7 cases (4.3%) were peripheral. Among the peripheral odontogenic tumors, there were three cases of peripheral ameloblastoma (42.8%), two cases of odontogenic myxoma, and one case each of odontoma and odontogenic fibroma.
Discussion
In the present study, ameloblastoma was the most common odontogenic tumor. The incidence of odontogenic tumors in the oromaxillofacial region was low and peripheral and malignant tumors were relatively rare.
Nevertheless, this study showed that odontogenic tumors occurred more frequently in females, especially in the third decade and in the posterior mandible than in the anterior area.
Histologically, EOT was most commonly found in the mandible and in men in their thirties. MixOT showed a similar pattern but females were affected more than males. Moreover, MOT occurred more in females and in the mandible but in the forth decade of life.
In the present study, the most common odontogenic tumor was ameloblastoma, followed by odontoma, odontogenic myxoma and adenomatoid odontogenic tumor each with 15 cases. Olgac et al. (15) , in their 32-year study, showed the same results. Ogunsalu (7) noted that ameloblastoma was the most common odontogenic tumor Table 2 Frequency of odontogenic tumors based on histologic origin Table 1 Relative frequency of all odontogenic tumors (85.5%), but found that odontoma was uncommon. Lu et al. (16) and Ochsenius et al. (17) also reported that ameloblastoma was the most common odontogenic tumor, and odontoma the forth most common. According to studies in Indian, Nigerian, and Tanzanian populations, ameloblastoma was the most common odontogenic tumor, followed by myxoma (4, 18, 19) . On the other hand, odontoma was the most common odontogenic tumor in studies performed in Europe and the United States, followed by ameloblastoma and odontogenic fibromyxoma (13,20- Fig. 1 Ameloblastic carcinoma. Fig. 2 Adenomatoid odontogenic tumor. Table 3 Frequency of the most common odontogenic tumors 24) (Table 4 ). In the present study, malignancy accounted for 1.8% of all the tumors, similar to other studies (7, 18, 19, 24) . Lu et al. (6) and Jing et al. (25) reported 6% malignancy in a Chinese population, whereas Fernandes (13) stated no malignancy among odontogenic tumors in a Brazilian population.
The majority of the cases in the present study were located centrally and only 4.3% peripherally, the most common one being peripheral ameloblastoma (42.8%). Bucher et al. (23, 26) showed that 99.95% of total odontogenic tumors were central and only 0.05% were peripheral, and that the most common peripheral tumor was odontogenic fibromyxoma. The posterior region of the jaws was the most common location for odontogenic tumors in the present study (mandible = 63%; maxilla = Table 4 Comparison of the present study with large studies reported from different countries and regions Fig. 4 Ameloblastic fibroma. Fig. 3 Ameloblastic fibro-odontoma. 15 .2%) followed by anterior maxilla (13.9%), which agreed with data from Olgac et al. (15) . Although various studies showed greater occurrence of odontogenic tumor in the mandible than maxilla, Jing et al. (25) showed more odontogenic tumors in the maxilla.
In the present study, more cases appeared in the third decade, the ages ranging from 6 to 81 years with a mean of approximately 26 years. Jing et al. (25) observed a median age of about 32. Occurrence was predominantly in the second and third decade of life, as stated by Santos et al. (12) and Fernandes et al. (13) , and was seen in a rather broad age group between second to fifth decades by Okada et al. (8) Furthermore, odontogenic tumors were seen more in females (53.9%), than in males which is similar to other studies (12, 13, 15) . Jing et al. (25) showed a fourfold increase in odontogenic tumors in females over males.
The most common clinical findings in the present study are summarized in Table 5 .
It should be added that according to the WHO classification in 2005, Odontogenic Keratocyst (OKC) has been renamed as Keratocystic Odontogenic Tumor (KCOT) and Calcifying Odontogenic Cyst (COC) has been renamed as Calcifying Cystic Odontogenic Tumor (CCOT). However, some of the standard references in the field of oral pathology (1,2) still use the term OKC. According to this, OKC has not been considered as a tumor in this research.
Our findings revealed a low frequency of odontogenic tumors among oromaxillofacial lesions and a small percentage of malignancy. Odontogenic tumors are more common in the mandible and in females with most cases appearing in the second and third decades of life.
